Clinical Trials Arena

Despite stringent European Union (EU) laws governing smaller medical device and pharma companies, the DACH region can be an attractive place to conduct clinical trials, according to industry leaders. Andrea Sauerland, senior vice-president of clinical operations at Endotronix, Enrico Perfler, founder of medtech contract research organisation (CRO) 1MED SA and Ina Meyer, study and site operations country manager for Switzerland at Novartis were speaking at our Annual Outsourcing in Clinical Trials DACH 2024 event which is taking place in Zurich, Switzerland, on 29–30 October. Click here for the full article - https://lnkd.in/gWKMSeT5 #clinicaltrials #clinicaloperations #contractresearch #CRO #medtech Outsourcing in Clinical Trials Event Series Arena International Events Group #pharma

Questions remain over costs and the participant experience when it comes to community-based research sites. However, conducting research in the community could create a more cost-effective and positive trial experience with fewer participant dropouts. Learn more in this article form PCM TRIALS - Quality Mobile Research - https://lnkd.in/d5S69jSR #clinicaltrials #clinicalresearch #DCTs #decentralizedclinicaltrials

Moderna and MSD have initiated a Phase III clinical study to evaluate mRNA-4157 (V940), an investigational individualised neoantigen therapy, in combination with Keytruda to treat non-small cell lung cancer (NSCLC). MSD Research Laboratories oncology and global clinical development senior vice-president and head Dr Marjorie Green said:“We are pleased to expand the INTerpath clinical trial programme with Moderna, evaluating V940 (mRNA-4157), a promising new modality, in combination with Keytruda to pursue meaningful advances for lung cancer and bring more options to patients with earlier stages of disease, where we potentially can have the most impact.” Click here for the full article - https://lnkd.in/dJC3_uCf #clinicaltrials #keytruda #lungcancer #oncology #mRNA

Our reporter Jenna Philpott is at the Outsourcing in Clinical Trials Event Series DACH conference in Zurich, Switzerland today and tomorrow. Great start to the day with sessions covering the ICH GCP E6 (R3) guidelines and patient centricity.

The United Arab Emirates (UAE)’s clinical research landscape, is quickly developing with a regulatory framework coming into place over the last few years, said Rohan Simon, associate director of business development at IROS CRO by M42 Health, the UAE’s first contract research organisation (CRO). Simon discussed the ins and outs of the UAE’s clinical trials ecosystem at our Outsourcing in Clinical Trials Conference in New England. Click here for the full article - https://lnkd.in/dQpD52-2 #UAEhealthcare #pharma #clinicaltrials #CRO #contractresearch #clinicaloutsourcing #clinicalresearch

Social media has become an excellent tool for targeting specific patients for clinical trials, says Chris Adams, C. - Andarix, the CEO at Andarix Pharmaceuticals, a biotech developing targeted oncology therapies. Adams was speaking at our Outsourcing in Clinical Trials conference in Boston, New England, being held 23 – 24 October, where experts discussed challenges and strategies surrounding clinical trial operations. Click here for the full article - https://lnkd.in/dwyiqKxM #clinicaltrials #pharma #raredisease #socialmedia #oncology

The pharmaceutical industry is undergoing significant changes, with clinical trials becoming increasingly complex and extending beyond traditional geographical boundaries. Novotech, a well-established global contract research organization (CRO), has been recognized for its strategic approach to navigating these changes, earning awards in Business Expansion, Innovation, and Marketing categories in the 2024 Clinical Trials Arena Excellence Awards. Novotech won the Business Expansion award for its strategic acquisitions and the launch of specialized units that enhance its international presence and service offerings. The Innovation award was given for Novotech’s adoption of advanced technologies such as artificial intelligence (AI) and big data to optimize clinical trial design and execution. The Marketing awards were earned through visionary leadership that successfully rebranded Novotech as a global CRO, with targeted multi-channel marketing strategies that resonated across diverse markets. Find out more here - https://lnkd.in/e75ZTtjE

Join SAP for their upcoming webinar! As the pharmaceutical industry advances into the era of cell and gene therapies, the complexity of managing clinical trial supply chains has grown exponentially. For companies navigating the high stakes of personalized treatments, the margin for error is non-existent. Each dose could mean the difference between life and death for patients. To meet these challenges head-on, innovative technology solutions are essential. Key Objectives: 👉 Gain insights into scaling clinical trials and reducing costs with cloud-based solutions. Learn to achieve real-time monitoring and end-to-end visibility for unmatched efficiency and compliance. 👉Explore methods to maintain rigorous regulatory compliance across the entire supply chain. 👉Understand the role of advanced technology in ensuring timely, optimal delivery of individualized treatments. 👉Discover how AI-driven tools enhance cell and gene therapy & clinical trials supply chain management. Speakers 🗣 Aparna S. Director, Life Science Solutions at SAP 🗣 Sri Chintamaneni Director, IT - SAP Enterprise Business Solutions - Supply Chain, Planning & Manufacturing at Gilead Sciences 🗣 Josh Fyffe Product Manager - Cell & Gene Therapy Orchestration Systems at Genentech / Roche 🗣 Wafaa Hassan Senior Pharma Analyst at GlobalData Healthcare 📅 4th November 2024 🕜 3pm London / 10am New York 👉 Click here to register for free - https://lnkd.in/ekebAWvR #supplychain #clinicalsupplychain #pharmasuppychain #celltherapy #genetherapy #CGTs #pharmalogistics #clinicalsupply #clinicaltrials #pharma #personalizedmedicine #ai #aiinhealthcare

Solutions are needed to bridge gaps in communication that can prevent underserved communities from entering diabetes clinical trials. We spoke to Renee Pekmezaris, PhD, a professor at the Institute of Health System Science in Feinstein Institutes for Medical Research, Louise Goff, PhD, a professor of Nutrition Science at the Leicester Diabetes Centre, Xoli Belgrave, Senior Director, Head of Clinical Trial Diversity and Inclusion at Parexel and Dr. Muhammad Karamat, a consultant physician and honorary professor in Diabetes and Endocrinology at University Hospitals Birmingham to learn more. Click here for the full article - https://lnkd.in/d9WErMqN #clinicaltrials #diabetes #trialdiversity #pharma

Large language models (LLMs) such as ChatGPT are frequently hailed as revolutionary tools for any workplace. However, in the pharma industry, smaller-scale supervised machine learning models could provide more effective and reliable solutions. Learn more in the article from Zelta by Merative - https://lnkd.in/eKFznVY4 #clinicaltrials #LLMs #ChatGPT #pharma #machinelearning